BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 27432059)

  • 1. The role of formyl peptide receptor 1 (FPR1) in neuroblastoma tumorigenesis.
    Snapkov I; Öqvist CO; Figenschau Y; Kogner P; Johnsen JI; Sveinbjørnsson B
    BMC Cancer; 2016 Jul; 16():490. PubMed ID: 27432059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Honokiol suppresses formyl peptide-induced human neutrophil activation by blocking formyl peptide receptor 1.
    Liu FC; Yu HP; Syu YT; Fang JY; Lin CF; Chang SH; Lee YT; Hwang TL
    Sci Rep; 2017 Jul; 7(1):6718. PubMed ID: 28751674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promotion of formyl peptide receptor 1-mediated neutrophil chemotactic migration by antimicrobial peptides isolated from the centipede Scolopendra subspinipes mutilans.
    Park YJ; Lee SK; Jung YS; Lee M; Lee HY; Kim SD; Park JS; Koo J; Hwang JS; Bae YS
    BMB Rep; 2016 Sep; 49(9):520-5. PubMed ID: 27502013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PEST-containing nuclear protein mediates the proliferation, migration, and invasion of human neuroblastoma cells through MAPK and PI3K/AKT/mTOR signaling pathways.
    Wu DD; Gao YR; Li T; Wang DY; Lu D; Liu SY; Hong Y; Ning HB; Liu JP; Shang J; Shi JF; Wei JS; Ji XY
    BMC Cancer; 2018 May; 18(1):499. PubMed ID: 29716528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. V101L of human formyl peptide receptor 1 (FPR1) increases receptor affinity and augments the antagonism mediated by cyclosporins.
    Zhou C; Zhou Y; Wang J; Feng Y; Wang H; Xue J; Chen Y; Ye RD; Wang MW
    Biochem J; 2013 Apr; 451(2):245-55. PubMed ID: 23373827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The formyl peptide receptor 1 exerts a tumor suppressor function in human gastric cancer by inhibiting angiogenesis.
    Prevete N; Liotti F; Visciano C; Marone G; Melillo RM; de Paulis A
    Oncogene; 2015 Jul; 34(29):3826-38. PubMed ID: 25263443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioactive secondary metabolites of a marine Bacillus sp. inhibit superoxide generation and elastase release in human neutrophils by blocking formyl peptide receptor 1.
    Yang SC; Lin CF; Chang WY; Kuo J; Huang YT; Chung PJ; Hwang TL
    Molecules; 2013 Jun; 18(6):6455-68. PubMed ID: 23736784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of formyl peptide receptor in high-grade astrocytoma by CHemotaxis Inhibitory Protein of S. aureus.
    Boer JC; Domanska UM; Timmer-Bosscha H; Boer IG; de Haas CJ; Joseph JV; Kruyt FA; de Vries EG; den Dunnen WF; van Strijp JA; Walenkamp AM
    Br J Cancer; 2013 Feb; 108(3):587-96. PubMed ID: 23322202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microenvironment involved in FPR1 expression by human glioblastomas.
    Boer JC; van Marion DM; Joseph JV; Kliphuis NM; Timmer-Bosscha H; van Strijp JA; de Vries EG; den Dunnen WF; Kruyt FA; Walenkamp AM
    J Neurooncol; 2015 May; 123(1):53-63. PubMed ID: 25894595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the AnxA1/FPR1 autocrine axis reduces MDA-MB-231 breast cancer cell growth and aggressiveness in vitro and in vivo.
    Vecchi L; Alves Pereira Zóia M; Goss Santos T; de Oliveira Beserra A; Colaço Ramos CM; França Matias Colombo B; Paiva Maia YC; Piana de Andrade V; Teixeira Soares Mota S; Gonçalves de Araújo T; Van Petten de Vasconcelos Azevedo F; Soares FA; Oliani SM; Goulart LR
    Biochim Biophys Acta Mol Cell Res; 2018 Sep; 1865(9):1368-1382. PubMed ID: 29932988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The formyl peptide receptor agonist FPRa14 induces differentiation of Neuro2a mouse neuroblastoma cells into multiple distinct morphologies which can be specifically inhibited with FPR antagonists and FPR knockdown using siRNA.
    Cussell PJG; Howe MS; Illingworth TA; Gomez Escalada M; Milton NGN; Paterson AWJ
    PLoS One; 2019; 14(6):e0217815. PubMed ID: 31170199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FPR1 gene silencing suppresses cardiomyocyte apoptosis and ventricular remodeling in rats with ischemia/reperfusion injury through the inhibition of MAPK signaling pathway.
    Zhou QL; Teng F; Zhang YS; Sun Q; Cao YX; Meng GW
    Exp Cell Res; 2018 Sep; 370(2):506-518. PubMed ID: 30031130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphatidylinositol 3-kinase, class 2 beta (PI3KC2β) isoform contributes to neuroblastoma tumorigenesis.
    Russo A; Okur MN; Bosland M; O'Bryan JP
    Cancer Lett; 2015 Apr; 359(2):262-8. PubMed ID: 25622909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel MtHSP70-FPR1 fusion protein enhances cytotoxic T lymphocyte responses to cervical cancer cells by activating human monocyte-derived dendritic cells via the p38 MAPK signaling pathway.
    Xiao M; Feng Y; Cao G; Liu C; Zhang Z
    Biochem Biophys Res Commun; 2018 Sep; 503(3):2108-2116. PubMed ID: 30098789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exogenous carbon monoxide inhibits neutrophil infiltration in LPS-induced sepsis by interfering with FPR1 via p38 MAPK but not GRK2.
    Wang X; Qin W; Song M; Zhang Y; Sun B
    Oncotarget; 2016 Jun; 7(23):34250-65. PubMed ID: 27144520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small-molecule-biased formyl peptide receptor agonist compound 17b protects against myocardial ischaemia-reperfusion injury in mice.
    Qin CX; May LT; Li R; Cao N; Rosli S; Deo M; Alexander AE; Horlock D; Bourke JE; Yang YH; Stewart AG; Kaye DM; Du XJ; Sexton PM; Christopoulos A; Gao XM; Ritchie RH
    Nat Commun; 2017 Feb; 8():14232. PubMed ID: 28169296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 4-Aroyl-3-hydroxy-5-phenyl-1H-pyrrol-2(5H)-ones as N-formyl peptide receptor 1 (FPR1) antagonists.
    Kirpotina LN; Schepetkin IA; Khlebnikov AI; Ruban OI; Ge Y; Ye RD; Kominsky DJ; Quinn MT
    Biochem Pharmacol; 2017 Oct; 142():120-132. PubMed ID: 28690139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NSC-87877 inhibits DUSP26 function in neuroblastoma resulting in p53-mediated apoptosis.
    Shi Y; Ma IT; Patel RH; Shang X; Chen Z; Zhao Y; Cheng J; Fan Y; Rojas Y; Barbieri E; Chen Z; Yu Y; Jin J; Kim ES; Shohet JM; Vasudevan SA; Yang J
    Cell Death Dis; 2015 Aug; 6(8):e1841. PubMed ID: 26247726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
    Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
    Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PI3K-mTORC2 but not PI3K-mTORC1 regulates transcription of HIF2A/EPAS1 and vascularization in neuroblastoma.
    Mohlin S; Hamidian A; von Stedingk K; Bridges E; Wigerup C; Bexell D; Påhlman S
    Cancer Res; 2015 Nov; 75(21):4617-28. PubMed ID: 26432405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.